Tc-99m MIBI SPECT in prediction of prognosis in patients with small cell lung cancer

Annals of Nuclear Medicine

Volumn 20, Issue 4, 2006, Pages 269-275

  Akgun, Aysegul ^a   Cok, Gursel ^a   Karapolat, Inanc ^a   Goksel, Tuncay ^a   Burak, Zeynep ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Chemotherapy; Multidrug resistance; Small cell lung cancer; Tc 99m MIBI

Indexed keywords

CISPLATIN; ETOPOSIDE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG RESPONSE; DRUG RETENTION; DRUG UPTAKE; FEMALE; FOLLOW UP; HUMAN; LUNG PARENCHYMA; LUNG SMALL CELL CANCER; MALE; PRIORITY JOURNAL; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL TIME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; CISPLATIN; ETOPOSIDE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; TURKEY;

EID: 33745865491     PISSN: 09147187     EISSN: 09147187     Source Type: Journal    
DOI: 10.1007/BF02984643     Document Type: Article

References (25)

1. Hoffmann PC, Mauer AM, Vokes Everett E. Lung Cancer. The Lancet 2000; 355: 479-485.
2. Spiro SG, Porter JC. Lung cancer - Where are we today? American Journal of Respiratory and Critical Care Medicine 2002; 166: 1166-1196.
3. Brock I, Hipfner DR, Nielsen BS, Jensen PB, Deeley RG, Cole SP, et al. Sequential coexpression of the multidrug resistance gene MRP and mdr1 and their products in products in VP-16 (Etoposide)-selected H69 small cell lung cancer. Cancer Res 1995; 55: 459-462.
4. Narasaki F, Matsuo I, Ikuno N, Fukuda M, Soda H, Oka M. Multidrug resistance-associated protein (MRP) gene expression in human lung cancer. Anticancer Res 1996; 16: 2079-2082.
5. Hendrikse NH, Fransseen EJF, Van der Graaf WTA, Vaalburg W, Vries de EGE. Visualization of multidrug resistance in vivo. Eur J Nucl Med 1999; 26: 283-293.
6. Moretti JL, Caglar M, Boaziz C, Caillat-Vigneron M, Morere JF. Sequential functional imaging with technetium-99m hexakis-2-methoxyisobutylisonitrile and indium-111 octreotide: can we predict the response to chemotherapy in small cell lung cancer? Eur J Nucl Med 1995; 22: 177-180.
7. Kao CH, ChangLai SP, Chieng PU, Yen TC. Technetium-99m methoxyisobutylisonitrile chest imaging of small cell lung carcinoma. Cancer 1998; 83: 64-68.
8. Canitrot Y, Bichat F, Cole SP, Deeley RG, Gerlach JH, Bastian G, et al. Multidrug resistance genes (MRP) and MDR1 expression in small cell lung cancer xenografts: relationship with response to chemotherapy. Cancer Lett 1998; 130: 133-141.
9. Shiau YC, Tsai SC, Wang JJ, Ho YJ, Ho ST, Kao CH. To predict chemotherapy response using technetium-99m tetrofosmin and compare with p-glycoprotein and multidrug resistance related protein-1 expression in patients with untreated small cell lung cancer. Cancer Lett 2001; 169: 181-188.
10. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxy isobutyl isonitrile) Tc-99m cultured mouse fibroblast. J Nucl Med 1990; 31: 1646-1653.
11. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured chick myocardial cells: mitochondrial and plasma membrane potential difference. Circulation 1990; 82: 1826-1838.
12. Kuo TH, Liu FY, Chuang CY, Wu HS, Wang JJ, Kao A. To predict response chemotherapy using technetium-99m tetrofosmin chest images in patients with untreated small cell lung cancer and compare with p-glycoprotein, multidrug resistance related protein-1, and lung resistance-related protein expression. Nucl Med Biol 2003; 30: 627-632.
13. Fukumoto M, Yoshida D, Hayase N, Kurohara A, Akagi N, Yoshida S. Scintigraphic prediction of resistance to radiation and chemotherapy in patients with lung carcinoma. Cancer 1999; 86: 1470-1479.
14. Nishiyama Y, Yamamoto Y, Satoh K, Ohkawa M, Kameyama K, Hayashi E, et al. Comparative study of Tc-99m MIBI and Tl-201 SPECT in predicting chemotherapeutic response in non-small-cell lung cancer. Clin Nucl Med 2000; 25: 364-369.
15. Yamamoto Y, Nishiyama Y, Satoh K, Takashima H, Ohkawa M, Fujita J, et al. Comparative study of technetium-99m- sestamibi and thallium-201 SPECT in predicting chemotherapeutic response in small cell lung cancer. J Nucl Med 1998; 39: 1626-1629.
16. Bom HS, Kim YC, Song HC, Min JJ, Kim JY, Park KO. Technetium-99m-MIBI uptake in small cell lung cancer. J Nucl Med 1998; 39: 91-94.
17. Ciarmiello A, Del Vecchio S, Silvestro P, Potena MI, Carriero MV, Thomas R, et al. Tumor clearance of technetium-99m sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer. J Clin Oncol 1998; 16: 1677-1683.
18. Del Vecchio S, Ciarmiello A, Pace L, Potena MI, Carriero MV, Mainolfi C, et al. Fractional retention of technetium-99m sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients. J Nucl Med 1997; 38: 1348-1351.
19. Burak Z, Ersoy O, Moretti JL, Erinç R, Özcan Z, Dirlik A, et al. The role Tc-99m MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response. Eur J Nucl Med 2001; 28: 1341-1350.
20. Budinger TF. Physical attributes of single-photon tomography. J Nucl Med 1980; 21: 579-592.
21. Moorin RE, Davison A, Turner JH. Optimization of technetium-99m sestamibi single-photon emission tomography to define multidrug resistance with confidence. Nucl Med Commun 2004; 25: 1039-1048.
22. Moretti JL, Azaloux H, Boisseron D, Kouyoumdjian JC, Vilcoq J. Primary breast cancer imaging with technetium-99m sestamibi an its relation P-glycoprotein overexpression. Eur J Nucl Med 1996; 23: 980-986.
23. 99mTc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma. Eur J Nucl Med Mol Imaging 2003; 30: 879-887.
24. Komori T, Narabayashi I, Matsui R, Sueyoshi K, Aratani T, Utsunomiya K. Technetium-99m MIBI single photon emission computed tomography as a indicator of prognosis for patients with lung cancer-preliminary report. Ann Nucl Med 2000; 14: 415-420.
25. 99mTc-MIBI in non-small cell lung cancer in relationship with pgp and prognosis. Eur J Nucl Med 2002; 29: 876-881.